<DOC>
	<DOCNO>NCT00272805</DOCNO>
	<brief_summary>The purpose study compare dose compliance study patient take controlled release carvedilol day , study patient take immediate release carvedilol ( Coreg ) twice day .</brief_summary>
	<brief_title>Drug Compliance Quality Life Patients With Heart Failure Dosed With Either Once-daily Twice-daily Coreg</brief_title>
	<detailed_description>Study Further Study Details : Primary outcome : pill-taking compliance ( total dos take versus total dos prescribe ) Expected Total Enrollment : 400 subject 56 study site U.S. Study Start : October 2005 This 5-month double-blind treatment study male female subject stable mild-to-severe chronic heart failure leave ventricular dysfunction symptom heart failure . Eligibility : Must stable treatment Coreg IR standard dose : 6.25 , 12.5 , 25 mg twice day .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Ability read English Stable symptom mild severe heart failure Stable medical regimen heart failure On stable dose Coreg least 2 month LVEF ≤40 % within previous 24 month Uncorrected obstructive regurgitant valve disease Complex congenital heart disease Recent ICD pacemaker placement Recent coronary artery bypass surgery stroke Candidate heart transplanct within 5 month study start Present plan use MAO inhibitor , alfphablockers , combine alphabeta blocker , Class I/II antiarrythmnic agent , ( amiodarone may use ≤ 200mg/day ) . Use intravenous vasodilator/inotropic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>chronic heart failure</keyword>
	<keyword>leave ventricular systolic dysfunction</keyword>
</DOC>